Voyager Therapeutics (VYGR) Q1 2026 Earnings

9MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.57
-0.53
-0.49
-0.45

Details

Expected EPS
-0.510572
Actual EPS
-0.46
Surprise EPS
0.05
Surprise Percent
+9.9%

Description

Voyager Therapeutics (VYGR) has reported earnings of -0.46 per share for Q1 2026.

0 Comments

Share your thoughts